Isolation and characterization of a human antibody fragment specific for Ts1 toxin from Tityus serrulatus scorpion.

No abstract is available for this paper.

• Publication year

  2011

• Venue

  Immunology Letters

• Publication date

  2011-09-30

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1016/j.imlet.2011.05.002PMID 21620895
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• A novel high‐affinity human monoclonal antibody to mesothelin

  2011cited by this paper
• Antibody fragments

  2010cited by this paper
• Development trends for human monoclonal antibody therapeutics

  2010cited by this paper
• Exploiting Cross-reactivity to Neutralize Two Different Scorpion Venoms with One Single Chain Antibody Fragment*

  2010cited by this paper
• In vivo protection against Tityus serrulatus scorpion venom by antibodies raised against a discontinuous synthetic epitope.

  2010cited by this paper
• Phage display: concept, innovations, applications and future.

  2010cited by this paper
• Antidotes against venomous animals: state of the art and prospectives.

  2009cited by this paper
• Phage Displayed scFv: pIII Scaffold May Fine Tune Binding Specificity

  2009cited by this paper
• Epidemiology of scorpionism: a global appraisal.

  2008cited by this paper
• Monoclonal antibodies in cancer therapy: 25 years of progress.

  2008cited by this paper
• Effective Tityus serrulatus anti-venom produced using the Ts1 component.

  2008cited by this paper
• Human monoclonal antibodies by immortalization of memory B cells

  2007cited by this paper
• Anticorps recombinants : vers une nouvelle génération d'antivenins ?

  2006cited by this paper
• Anticorps monoclonaux et recombinants, 30 ans déjà...

  2006cited by this paper
• [Monoclonal antibodies, 30 years of success].

  2006cited by this paper
• Proteomic analysis of the venom and characterization of toxins specific for Na+ - and K+ -channels from the Colombian scorpion Tityus pachyurus.

  2006cited by this paper
• [Recombinant antibodies: towards a new generation of antivenoms?].

  2006cited by this paper
• A strategy for the generation of specific human antibodies by directed evolution and phage display

  2005cited by this paper
• Monoclonal and recombinant antibodies, 30 years after …

  2005cited by this paper
• Scorpion envenoming in two regions of Colombia: clinical, epidemiological and therapeutic aspects.

  2004cited by this paper
• Improving selection of αIIbβ3-binding phage antibodies with increased reactivity derived from immunized donors

  2003cited by this paper
• IMGT® databases, web resources and tools for immunoglobulin and T cell receptor sequence analysis, http://imgt.cines.fr

  2003cited by this paper
• Improving selection of alphaIIbbeta3-binding phage antibodies with increased reactivity derived from immunized donors.

  2003cited by this paper
• Single-chain Fv fragment lacks carrier specificity of the native antibody.

  2002cited by this paper
• Scorpion toxins from Tityus cambridgei that affect Na(+)-channels.

  2002cited by this paper
• Functional improvement of antibody fragments using a novel phage coat protein III fusion system.

  2002cited by this paper
• Stability engineering of antibody single-chain Fv fragments.

  2001cited by this paper
• [Poisonous sting by Tityus stigmurus (Scorpiones; Buthidae) in the state of Bahia, Brazil].

  2000cited by this paper
• Selection of high-affinity phage antibodies from phage display libraries

  1999cited by this paper
• IMGT, the international ImMunoGeneTics database

  1997cited by this paper
• Selective Usage of VH Genes in Adult Human B Lymphocyte Repertoires

  1997cited by this paper
• Fab fragments of the monoclonal antibody BCF2 are capable of neutralizing the whole soluble venom from the scorpion Centruroides noxius Hoffmann.

  1996cited by this paper
• The Expressed Heavy Chain V Gene Repertoire of Circulating B Cells in Normal Adults a

  1995cited by this paper
• Scorpionism and serotherapy in Mexico.

  1994cited by this paper
• Amino acid sequence and immunological characterization with monoclonal antibodies of two toxins from the venom of the scorpion Centruroides noxius Hoffmann.

  1992cited by this paper
• By-passing immunization. Human antibodies from V-gene libraries displayed on phage.

  1991cited by this paper
• Basic local alignment search tool.

  1990cited by this paper
• Modification of Na channel gating by an alpha scorpion toxin from Tityus serrulatus

  1989cited by this paper
• Scorpion toxins from Centruroides noxius and Tityus serrulatus. Primary structures and sequence comparison by metric analysis.

  1985cited by this paper
• Filamentous fusion phage: novel expression vectors that display cloned antigens on the virion surface.

  1985cited by this paper
• Purification and chemical characterization of the major toxins from the venom of the Brazilian scorpion Tityus serrulatus Lutz and Mello

  1981cited by this paper
• Electrophoretic transfer of proteins from polyacrylamide gels to nitrocellulose sheets: procedure and some applications.

  1979cited by this paper
• Continuous cultures of fused cells secreting antibody of predefined specificity

  1975cited by this paper
• The Up-and-Down Method for Small Samples

  1965cited by this paper

• Behavior and oxidative stress evaluation of scorpion Tityus serrulatus (Lutz & Mello,1922) envenomation with genomic modulation and dopaminergic neutralization by antiscorpionic serum treatment.

  2025cites this paper
• Production of recombinant scorpion antivenoms in E. coli: current state and perspectives

  2023cites this paper
• Developing Recombinant Antibodies by Phage Display Against Infectious Diseases and Toxins for Diagnostics and Therapy

  2021cites this paper
• Scorpion species of medical importance in the Brazilian Amazon: a review to identify knowledge gaps

  2021cites this paper
• Scorpion envenomation: a deadly illness requiring an effective therapy

  2020cites this paper
• Microbial production of toxins from the scorpion venom: properties and applications

  2018cites this paper
• Ts1 from the Brazilian scorpion Tityus serrulatus: A half‐century of studies on a multifunctional beta like‐toxin

  2018cites this paper
• Pros and cons of different therapeutic antibody formats for recombinant antivenom development

  2018cites this paper
• Establishment of a sensitive time-resolved fluoroimmunoassay for detection of Bacillus thuringiensis Cry1Ie toxin based nanobody from a phage display library.

  2017cites this paper
• Recombinant antibodies for diagnostics and therapy against pathogens and toxins generated by phage display

  2016cites this paper
• Protein Targeting Compounds

  2016influential citation
• Generation of Recombinant Antibodies Against Toxins and Viruses by Phage Display for Diagnostics and Therapy

  2016cites this paper
• Human scFv antibodies (Afribumabs) against Africanized bee venom: Advances in melittin recognition.

  2016cites this paper
• Biotechnological Trends in Spider and Scorpion Antivenom Development

  2016influential citation
• Evolution of alternative methodologies of scorpion antivenoms production.

  2015cites this paper
• Neutralizing Effects of Mimosa tenuiflora Extracts against Inflammation Caused by Tityus serrulatus Scorpion Venom

  2014cites this paper
• Serrumab: A novel human single chain-fragment antibody with multiple scorpion toxin-neutralizing capacities

  2014cites this paper
• Engineering Venom’s Toxin-Neutralizing Antibody Fragments and Its Therapeutic Potential

  2014cites this paper
• Antarease-like Zn-metalloproteases are ubiquitous in the venom of different scorpion genera.

  2014cites this paper
• Study of mechanism of action of Scorpion neurotoxins

  2013cites this paper
• Recombinant Neutralizing Antibodies, A New Generation of Antivenoms

  2013cites this paper
• Identification and Phylogenetic Analysis of Tityus pachyurus and Tityus obscurus Novel Putative Na+-Channel Scorpion Toxins

  2012cites this paper
• Serrumab: A human monoclonal antibody that counters the biochemical and immunological effects of Tityus serrulatus venom

  2012cites this paper
• Isolation of single chain variable fragment (scFv) specific for Cry1C toxin from human single fold scFv libraries.

  2012cites this paper